Makoto Kawase

Gifu University, Gifu University Hospital

Papers

29

Total Citations

138

H-Index

7

About

Makoto Kawase is a urological surgeon and clinical researcher whose work centers on robotic and minimally invasive surgery for urological cancers, with a particular focus on prostate cancer management. Based primarily in Japan, Kawase has established himself as a leading contributor to the evidence base surrounding robot-assisted radical prostatectomy (RARP), interrogating fundamental questions about surgical technique, oncological outcomes, and patient selection. Among his most significant contributions is his leadership within the MSUG94 multicenter research group, through which he has produced landmark studies examining the therapeutic value of pelvic lymph node dissection in RARP patients — work that has prompted important reconsiderations of standard surgical practice. His research into lymphovascular invasion, positive surgical margin locations, and cytoreductive prostatectomy for metastatic prostate cancer reflects a sophisticated approach to prognostic stratification. Kawase has also advanced surgical education, validating standardized training systems for RARP at low-volume institutions. Beyond prostate cancer, his portfolio extends to renal cell carcinoma and rare presentations of bladder cancer. With his most-cited papers accumulating dozens of citations within just a few years of publication, Kawase's multicenter, data-driven methodology continues to shape clinical decision-making across Japanese urology and beyond.

Research Focus

Key Achievements

7
H-Index
29
Papers
138
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Pelvic Lymphadenectomy May Not Improve Biochemical Recurrence-Free Survival in Patients with Prostate Cancer Treated with Robot-Assisted Radical Prostatectomy in Japan (The MSUG94 Group)
15 citations · 2022
📈 Most Prolific Year: 2024 (9 Papers)
🤝 Key Collaborators: 77
🏛 Institutions: Gifu University, Gifu University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago